查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
美国儿科心臟病市场规模和预测、国家份额、趋势和成长机会分析报告范围：按产品类型、手术程序、最终用户、疾病适应症和国家/地区
市场调查报告书
商品编码
1591399

美国儿科心臟病市场规模和预测、国家份额、趋势和成长机会分析报告范围：按产品类型、手术程序、最终用户、疾病适应症和国家/地区

US Pediatric Cardiology Market Size and Forecast, Country Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Surgical Procedures, End User, Disease Indication, and Country
出版日期: | 出版商: The Insight Partners | 英文 128 Pages | 订单完成后即时交付

价格

美国儿科心臟病市场规模预计将从 2023 年的 25.4 亿美元增至 2031 年的 35.9 亿美元。

儿科心臟病学是医学的一个专业分支，专注于诊断、治疗和管理婴儿、儿童和青少年的心臟病。该领域解决一系列先天性（出生时存在）和后天性心臟缺陷，包括室间隔缺损、房间隔缺损以及需要手术干预的更复杂的问题。

公司的策略倡议

在美国儿科心臟病市场营运的公司不断关注产品批准、合作、融资、协议和新产品发布等策略发展，这有助于他们提高销售额、地理覆盖范围和满足广泛客户群的能力。以下提到了美国儿科心臟病学市场主要参与者采取的一些策略性倡议：

2024年1月，Occlutech获得美国食品药物管理局（FDA）核准用于治疗心房中隔缺损（ASD）的Occlutech Pistol Pusher和Occlutech ASD封堵器。获得批准后，Occlutech 将立即与经销商B. Braun Interventional Systems Inc. 独家合作开始商业化。伞形柔性盘组成中间连接两个圆盘。

2023 年2 月，美敦力重新推出Harmony 经导管肺动脉瓣(TPV) 系统，这是一种微创心臟直视手术替代方案，适用于患有天然或手术修復右心室流出道(RVOT) 的先天性心臟病患者。该系统是为患有 RVOT 异常的患者设计的，这些患者还患有严重的肺动脉瓣逆流，这是一种血液被泵入肺部后渗漏到心臟右下腔的情况。

2022 年 5 月，Occlutech 与 B. Braun Interventional Systems Inc (BIS) 签署了独家经销协议。 BIS 将在全球 Occlutech 团队的支持下启动 Occlutech Flex II ASD 封堵器在美国的商业化活动。透过此次合作，Occlutech 在具有重要战略意义的美国市场取得了成功，该市场的特点是具有首要且具有商业吸引力的医疗保健系统。此外，BIS 透过对先天性和结构性心臟的强烈关注，提高了其投资组合的相关性。

因此，各公司专注于儿科心臟病设备开发的策略倡议可能会在未来几年为美国儿科心臟病市场提供成长机会。

然而，熟练的儿科心臟病专家的缺乏正在影响患有心血管疾病的儿童的护理的可用性和品质。随着先天性心臟病和其他心臟病的发病率持续上升，对专业心臟病学服务的需求正在超过训练有素的专业人员的供应。此外，人们对预防性心臟病护理的认识不断提高，以解决出生后立即出现的长期儿科心臟病问题。据美国儿科学会称，儿科心臟病专家明显短缺，特别是在美国农村和服务不足的地区，这些地区获得专业护理的机会往往有限。根据美国儿科委员会 (ABP) 截至 2023 年 6 月的资料，已有 4,117 名儿科心臟病专家获得了委员会认证，其中 3,096 名 (75%) 积极参与了认证维持 (MOC)。当劳动力仅限于美国时，到2023 年，每个州平均有57.3 名经过委员会认证的儿科心臟科医生（范围0-329），即每10 万名17 岁以下儿童（范围0.0-25.4）就有4 名心臟科医生。各州内儿科心臟科专家的分布有很大差异，大多数集中在城市地区，很少在农村地区。儿科心臟科专家的短缺也增加了现有从业人员的压力，导致倦怠和工作不满。这种情况最终会影响患者的治疗结果，因为过度劳累的专家可能无法为复杂病例提供所需的全面护理。因此，熟练的儿科心臟病专家的缺乏阻碍了市场的成长。

基于最终用户的见解

根据最终用户，儿科心臟病市场分为医院、专科诊所等。 2023 年，医院细分市场占据主导地位。先天性心臟病和其他心臟病病例的不断增加，要求儿科心臟中心拥有现代技术和多学科团队进行综合治疗。波士顿儿童医院、德州儿童医院、西雅图儿童医院和费城儿童医院都是公认的领导者，拥有最先进的设施和创新的儿科心臟病学方法，包括微创外科技术和介入手术。这些医院强调协作护理，心臟科医生与其他外科医生、麻醉师和护理人员合作，以确保优化治疗结果。西雅图儿童医院在 2023 年进行了约 570 例儿科心臟手术。健康系统中加强的专业护理和治疗方案可确保医院部门的成长和儿科心臟病学的进步，这将改善患有心血管问题的年轻患者的生活品质。

美国心臟病学会、儿童心臟基金会、疾病管制与预防中心、美国食品药物管理局、美国儿科学会是准备美国儿科心臟病市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 主要见解

第 3 章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：美国儿科心臟病学市场格局

  • 概述
  • PEST分析
  • 美国胸骨切开术手术分析

第 5 章：美国儿科心臟病市场 - 主要市场动态

  • 美国儿科心臟病市场 - 主要市场动态
  • 市场驱动因素
    • 儿科先天性心臟病发生率不断增加
    • 越来越多地转向微创手术
  • 市场限制
    • 缺乏熟练的儿科心臟科专家
  • 市场机会
    • 公司的策略倡议
  • 未来趋势
    • 人工智慧和机器学习与儿科心臟病学的整合
  • 驱动因素和限制的影响：

第 6 章：美国儿科心臟病市场分析

  • 美国儿科心臟病市场收入，2021-2031

第 7 章：美国儿科心臟病市场分析 - 按产品类型

  • 经导管心臟瓣膜
  • 封堵器
  • 斑块切除装置
  • 导管
  • 支架
  • 导管鞘
  • 其他的

第 8 章：美国儿科心臟病学市场分析 - 按手术程序

  • 介入治疗
  • 心律管理程式
  • 其他的

第 9 章：美国儿科心臟病学市场分析 - 按最终用户

  • 医院
  • 专科诊所
  • 其他的

第 10 章：美国儿科心臟病学市场分析 - 按疾病适应症

  • 患者卵圆孔 (PFO)
  • 先天性心臟病
  • 后天性心臟病
  • 心律不整
  • 心肌病变
  • 其他的

第 11 章：产业格局

  • 概述
  • 美国儿科心臟病市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：公司简介

  • Abbott Laboratories
  • Medtronic Plc
  • Edwards Lifesciences Corp
  • Terumo Corp
  • W L Gore and Associates Inc
  • NuMED
  • Cordis Corp
  • Occlutech US LLC
  • Biotronik SE & Co KG
  • RENATA MEDICAL

第 13 章：附录

Product Code: TIPRE00039351

The US pediatric cardiology market size is projected to reach US$ 3.59 billion by 2031 from US$ 2.54 billion in 2023. The market is expected to register a CAGR of 4.4% during 2023-2031.

Pediatric cardiology is a specialized branch of medicine that focuses on diagnosing, treating, and managing heart conditions in infants, children, and adolescents. This field addresses a range of congenital (present at birth) and acquired heart defects, including conditions like ventricular septal defects, atrial septal defects, and more complex issues requiring surgical intervention.

Strategic Initiatives by Companies

Companies operating in the US pediatric cardiology market constantly focus on strategic developments such as product approvals, collaborations, funding, agreements, and new product launches, which help them boost their sales, geographic reach, and capacities to cater to a wide customer base. A few strategic initiatives taken by key players operating in the US pediatric cardiology market are mentioned below:

In January 2024, Occlutech received the United States Food and Drug Administration (FDA) for Occlutech Pistol Pusher and Occlutech ASD Occluder for the treatment of atrial septal defects (ASD). With this approval, Occlutech will immediately commence commercialization in an exclusive partnership with distributor B. Braun Interventional Systems Inc. The Occlutech ASD occluder is a nitinol, self-expanding, double-disc occlusion device that comprises two umbrella-shaped flexible discs with a waist in the middle connecting the two discs.

In February 2023, Medtronic relaunched its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired right ventricular outflow tract (RVOT). The system was designed for patients suffering from RVOT anomalies who also develop severe pulmonary valve regurgitation, a condition where blood leaks into the right lower chamber of the heart after being pumped into the lungs.

In May 2022, Occlutech signed an exclusive distribution agreement with B. Braun Interventional Systems Inc (BIS). BIS will initiate the US commercialization activities for Occlutech's Flex II ASD Occluder with the support of the global Occlutech team. Through this collaboration, Occlutech records success in the strategically important US market, which is characterized as a premier and commercially attractive healthcare system. Also, BIS increases its portfolio's relevancy through strong congenital and structural heart focus.

Therefore, strategic initiatives by various companies focusing on the development of pediatric cardiology devices are likely to offer growth opportunities to the US pediatric cardiology market in the coming years.

However, the dearth of skilled pediatric cardiologists is impacting the availability and quality of care for children with cardiovascular conditions. As the incidence of congenital heart defects and other cardiac diseases continues to rise, the demand for specialized cardiology services is outpacing the supply of trained professionals. In addition, there is increasing awareness about preventive cardiology care to address long-term pediatric cardiology disorders immediately after birth. According to the American Academy of Pediatrics, there is a notable shortage of pediatric cardiologists, particularly in rural and underserved areas in the US, where access to specialized care is often limited. Based on the American Board of Pediatrics (ABP) data through June 2023, 4,117 pediatric cardiologists have ever been board-certified, of which 3,096 (75%) were actively enrolled in Maintenance of Certification (MOC). When the workforce is limited to the US, there was an average of 57.3 board-certified pediatric cardiologists per state (range 0-329) in 2023, which accounts for 4 cardiologists per 100,000 children aged to 17 years (range 0.0-25.4) across the US. There was wide variability in the distribution of pediatric cardiologists within states, with most concentrated in urban settings and few in rural areas. The shortage of pediatric cardiologists also contributes to increased pressure on existing practitioners, leading to burnout and job dissatisfaction. This situation can ultimately affect patient outcomes, as overworked specialists might not be able to provide the comprehensive care needed for complex cases. Thus, the dearth of skilled pediatric cardiologists hampers the market growth.

End User-Based Insights

Based on end users, the pediatric cardiology market is categorized into hospitals, specialty clinics, and others. The hospitals segment dominated the market in 2023. In the US pediatric cardiology market, the hospitals segment is significant in terms of delivering specialized care to children suffering from cardiovascular disorders. The increasing cases of congenital heart defects and other heart diseases have elevated pediatric cardiac centers with modern technologies and multidisciplinary teams for comprehensive treatment. Boston Children's Hospital, Texas Children's Hospital, Seattle Children's Hospital, and the Children's Hospital of Philadelphia are among the acknowledged leaders, boasting state-of-the-art facilities and innovative approaches to pediatric cardiology-including minimally invasive surgical techniques and interventional procedures. These hospitals emphasize collaborative care, where a cardiologist works with other surgeons, anesthesiologists, and nursing staff to ensure optimized treatment results. Seattle Children's Hospital performed ~570 pediatric heart surgeries in 2023. Recent investments in telemedicine and remote monitoring technologies further enhance patient management, with constant care and follow-up, highly necessary for patients located in rural areas. Access to specialized care and treatment protocols enhanced in health systems ensures growth in the hospitals segment and advancements in pediatric cardiology, which will improve the quality of life for young patients suffering from cardiovascular problems.

American College of Cardiology, Children's Heart Foundation, Centers for Disease Control and Prevention, United States Food and Drug Administration, and American Academy of Pediatrics are among the primary and secondary sources referred to while preparing the US pediatric cardiology market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. US Pediatric Cardiology Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 US Sternotomy Procedure Analysis

5. US Pediatric Cardiology Market - Key Market Dynamics

  • 5.1 US Pediatric Cardiology Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Incidence of Congenital Heart Disease in Pediatrics
    • 5.2.2 Growing Shift Toward Minimally Invasive Procedures
  • 5.3 Market Restraints
    • 5.3.1 Dearth of Skilled Pediatric Cardiologists
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Companies
  • 5.5 Future Trends
    • 5.5.1 Integration of AI and Machine Learning with Pediatric Cardiology
  • 5.6 Impact of Drivers and Restraints:

6. US Pediatric Cardiology Market Analysis

  • 6.1 US Pediatric Cardiology Market Revenue (US$ Million), 2021-2031

7. US Pediatric Cardiology Market Analysis - by Product Type

  • 7.1 Transcatheter Heart Valves
    • 7.1.1 Overview
    • 7.1.2 Transcatheter Heart Valves: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Occlusion Devices
    • 7.2.1 Overview
    • 7.2.2 Occlusion Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Atherectomy Devices
    • 7.3.1 Overview
    • 7.3.2 Atherectomy Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Catheters
    • 7.4.1 Overview
    • 7.4.2 Catheters: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Stents
    • 7.5.1 Overview
    • 7.5.2 Stents: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Introducer Sheaths
    • 7.6.1 Overview
    • 7.6.2 Introducer Sheaths: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

8. US Pediatric Cardiology Market Analysis - by Surgical Procedures

  • 8.1 Interventional Procedures
    • 8.1.1 Overview
    • 8.1.2 Interventional Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Heart Rhythm Management Procedures
    • 8.2.1 Overview
    • 8.2.2 Heart Rhythm Management Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Others
    • 8.3.1 Overview
    • 8.3.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

9. US Pediatric Cardiology Market Analysis - by End User

  • 9.1 Hospitals
    • 9.1.1 Overview
    • 9.1.2 Hospitals: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Specialty Clinics
    • 9.2.1 Overview
    • 9.2.2 Specialty Clinics: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Others
    • 9.3.1 Overview
    • 9.3.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

10. US Pediatric Cardiology Market Analysis - by Disease Indication

  • 10.1 Patient Foramen Ovale (PFO)
    • 10.1.1 Overview
    • 10.1.2 Patient Foramen Ovale (PFO): US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Congenital Heart Disease
    • 10.2.1 Overview
    • 10.2.2 Congenital Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Acquired Heart Disease
    • 10.3.1 Overview
    • 10.3.2 Acquired Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Arrhythmias
    • 10.4.1 Overview
    • 10.4.2 Arrhythmias: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Cardiomyopathies
    • 10.5.1 Overview
    • 10.5.2 Cardiomyopathies: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in US Pediatric Cardiology Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Edwards Lifesciences Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Terumo Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 W L Gore and Associates Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 NuMED
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Cordis Corp
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Occlutech US LLC
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Biotronik SE & Co KG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 RENATA MEDICAL
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. US Pediatric Cardiology Market Segmentation
  • Table 2. US Pediatric Cardiology Market - Volume and Forecast to 2031 (Units) - by Product Type
  • Table 3. US Pediatric Cardiology Market - Volume and Forecast to 2031 (Units) - by Surgical Procedures
  • Table 4. US Pediatric Cardiology Market - Volume and Forecast to 2031 (Units) - by Disease Indication
  • Table 5. Recent Organic Growth Strategies in US Pediatric Cardiology Market
  • Table 6. Recent Inorganic Growth Strategies in the US Pediatric Cardiology Market
  • Table 7. Glossary of Terms, US Pediatric Cardiology Market

List Of Figures

  • Figure 1. US Pediatric Cardiology Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. US Pediatric Cardiology Market Revenue (US$ Million), 2021-2031
  • Figure 5. US Pediatric Cardiology Market Share (%) - by Product Type, 2023 and 2031
  • Figure 6. Transcatheter Heart Valves: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Occlusion Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Atherectomy Devices: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Catheters: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Stents: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Introducer Sheaths: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. US Pediatric Cardiology Market Share (%) - by Surgical Procedures, 2023 and 2031
  • Figure 14. Interventional Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Heart Rhythm Management Procedures: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. US Pediatric Cardiology Market Share (%) - by End User, 2023 and 2031
  • Figure 18. Hospitals: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Specialty Clinics: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. US Pediatric Cardiology Market Share (%) - by Disease Indication, 2023 and 2031
  • Figure 22. Patient Foramen Ovale (PFO): US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Congenital Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Acquired Heart Disease: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Arrhythmias: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Cardiomyopathies: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Others: US Pediatric Cardiology Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Growth Strategies in US Pediatric Cardiology Market